Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +471.16% |
|
-.--% | +471.16% |
20/05 | Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
30/04 | Bioethics, Ltd. Appoints Doug Morris as A Member of Board of Directors | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Scharmann
CEO | Chief Executive Officer | 65 | 24/15/24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Scharmann
CEO | Chief Executive Officer | 65 | 24/15/24 |
Director/Board Member | 65 | 19/19/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,135,194 | 130,184 ( 11.47 %) | 0 | 11.47 % |
Company contact information
Bioethics Ltd.
1661 Lakeview Circle
84403, Ogden
+
![address Bioethics, Ltd.(BOTH)](https://cdn.zonebourse.com/static/address/11094835.png)
1st Jan change | Capi. | |
---|---|---|
+471.16% | 13.62L | |
+89.20% | 613.5Cr | |
+98.02% | 123.22Cr | |
+2.57% | 99Cr | |
+17.58% | 76Cr | |
+2.11% | 67Cr | |
+2.33% | 62Cr | |
-.--% | 60Cr | |
+8.61% | 53Cr | |
-.--% | 50Cr |
- Stock Market
- Equities
- BOTH Stock
- Company Bioethics, Ltd.